A haplotype of glycogen synthase kinase 3 β is associated with early onset of unipolar major depression
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Recent findings suggest that glycogen synthase kinase 3 β (GSK3β) may play a role in the pathophysiology and treatment of mood disorders. Various genetic studies have shown the association of GSK3β polymorphisms with different mood disorder phenotypes. We hypothesized that genetic variants in the GSK3β gene could partially underlie the susceptibility to mood disorders. We performed a genetic case–control study of 440 psychiatrically screened control subjects and 445 mood disorder patients [256 unipolar major depressive disorder (MDD) and 189 bipolar disorder (BD)]. We genotyped a set of 11 single nucleotide polymorphisms (SNPs) and determined the relative frequency of a known copy number variant (CNV) overlapping the GSK3β by quantitative real‐time polymerase chain reaction (PCR). We found no evidence of association with MDD or BD diagnosis, and we further investigated the age at onset (AAO) of the disorder and severity of depressive index episode. We found that rs334555, located in intron 1 of GSK3β, was nominally associated with an earlier AAO of the disease in MDD (P = 0.001). We also identified a haplotype containing three SNPs (rs334555, rs119258668 and rs11927974) associated with AAO of the disorder (permutated P = 0.0025). We detected variability for the CNV, but we could not detect differences between patients and controls for any of the explored phenotypes. This study presents further evidence of the contribution of GSK3β to mood disorders, implicating a specific SNP and a haplotype with an earlier onset of the disorder in a group of well‐characterized patients with unipolar MDD. Further replication studies in patients with the same phenotypic characteristics should confirm the results reported here.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of large-scale variation in the human genome
Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892 · cited 4×
“33 that contains a known CNV (Iafrate et al. 2004), which has recently been reported to present more gains in BD patients than in control individuals (Lachman et al.”
BackgroundResultInfluentialSearle, S. R., Casella, G., & McCulloch, C. E. (1992) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316856 · Cited by 1,926
The complete genome of an individual by massively parallel DNA sequencing
Wheeler, D. A., Srinivasan, M., Egholm, M., Shen, Y., Chen, L., McGuire, A., He, W., Chen, Y.-J., Makhijani, V., Roth, G. T., et al. (2008) · Nature · doi:10.1038/nature06884 · Cited by 1,838 · cited 1×
“In fact, two other smaller variations within this same CNV have been reported using more suitable methods to refine their boundaries and all of them involve the NR1I2 gene, not GSK3β (Mills et al. 2006; Wheeler et al. 2008) (Fig.”
BackgroundThe genetics of depression: A review
Levinson, D. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.024 · Cited by 855
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774 · cited 1×
“Among them, the β-isoform of glycogen synthase kinase 3 (GSK3β), which is particularly abundant in the central nervous system, has been identified as being involved in neuropsychiatric disorders including Alzheimer’s disease, schizophrenia and BD (Grimes & Jope 2001; Jope et al. 2007).”
BackgroundAn initial map of insertion and deletion (INDEL) variation in the human genome
Mills, R. E., Luttig, C. T., Larkins, C. E., Beauchamp, A., Tsui, C., Pittard, W. S., & Devine, S. E. (2006) · Genome Research · doi:10.1101/gr.4565806 · Cited by 673
Copy-number variations associated with neuropsychiatric conditions
Cook Jr, E. H., & Scherer, S. W. (2008) · Nature · doi:10.1038/nature07458 · Cited by 659
In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain
Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300 · cited 1×
“Accordingly, enhanced serotonergic activity or antidepressants acting on serotonergic systems cause inhibition of GSK3β (Li et al. 2004).”
BackgroundGSK3B polymorphisms alter transcription and splicing in Parkinson's disease
Kwok, J. B. J., Hallupp, M., Loy, C. T., Chan, D. K. Y., Woo, J., Mellick, G. D., Buchanan, D. D., Silburn, P. A., Halliday, G. M., & Schofield, P. R. (2005) · Annals of Neurology · doi:10.1002/ana.20691 · Cited by 205 · cited 1×
“This intronic SNP, known to alter a splice acceptor site of the gene (Kwok et al. 2005), was genotyped in our study but was not associated with our studied phenotypes.”
BackgroundBenedetti, F., Serretti, A., Colombo, C., Lorenzi, C., Tubazio, V., & Smeraldi, E. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.050 · Cited by 195 · cited 2×
“We interrogated for MDD and BD diagnoses, and also for the AAO and severity of the depressive index episode, which are phenotypes previously reported to be associated with this gene (Benedetti et al. 2004).”
BackgroundMethod
Cited by
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
Duman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
Eldar-Finkelman, H., & Martinez, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00032 · Cited by 354
Amare, A. T., Schubert, K. O., Klingler-Hoffmann, M., Cohen-Woods, S., & Baune, B. T. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.261 · Cited by 345
GSK3β: a master player in depressive disorder pathogenesis and treatment responsiveness
Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A. (2020) · Cells · doi:10.3390/cells9030727 · Cited by 84
“Its C/C and C/G genotypes are associated with the late age of onset (about 46 and 41 years old on average, respectively), whereas its G/G genotype with the early (about 28 years old on average) onset of depression [56].”
Background
Metadata
- Authors
- Saus, E., Soria, V., Escaramís, G., Crespo, J. M., Valero, J., Gutiérrez‐Zotes, A., Martorell, L., Vilella, E., Menchón, J. M., Estivill, X., Gratacòs, M., & Urretavizcaya, M.
- Venue
- Genes, Brain and Behavior
- Publisher
- Wiley
- Published
- 2010-07-07
- Volume
- 9
- Issue
- 7
- Pages
- 799-807
- ISSN
- 1601-183X (ISSN-L)
- 1601-1848
- OpenAlex
- W2016218688
- Cited by
- 51
- References
- 15
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A haplotype of glycogen synthase kinase 3 β is associated with early onset of unipolar major depression. https://app.cochat.ai/papers/10.1111/j.1601-183x.2010.00617.x
- The paper
- Saus, E., Soria, V., Escaramís, G., Crespo, J. M., Valero, J., Gutiérrez‐Zotes, A., Martorell, L., Vilella, E., Menchón, J. M., Estivill, X., Gratacòs, M., & Urretavizcaya, M. (2010). A haplotype of glycogen synthase kinase 3 β is associated with early onset of unipolar major depression. Genes, Brain and Behavior. https://doi.org/10.1111/j.1601-183x.2010.00617.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.